United States Prostate Cancer Medicine Market Report 2017

November 2017 | 103 pages | ID: UCBA0DE2643WEN
QYResearch

Abstracts

In this report, the United States Prostate Cancer Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Prostate Cancer Medicine in these regions, from 2012 to 2022 (forecast).

United States Prostate Cancer Medicine market competition by top manufacturers/players, with Prostate Cancer Medicine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca plc
• Active Biotech
• Bristol Myers-Squibb
• Teva Pharmaceuticals Industries Ltd.
• Johnson & Johnson
• Pfizer Inc.
• Bayer AG
• Abbott Laboratories
• Astellas Pharma Inc.
• Roche Holding AG

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Hormonal Therapy Drugs
• Chemotherapy Drugs
• Immunotherapy Drugs
• Target Therapy Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Prostate Cancer Medicine for each application, including

• Hospital
• Pharmacy
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Prostate Cancer Medicine Market Report 2017

1 PROSTATE CANCER MEDICINE OVERVIEW

1.1 Product Overview and Scope of Prostate Cancer Medicine
1.2 Classification of Prostate Cancer Medicine by Product Category
  1.2.1 United States Prostate Cancer Medicine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Prostate Cancer Medicine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Hormonal Therapy Drugs
  1.2.4 Chemotherapy Drugs
  1.2.5 Immunotherapy Drugs
  1.2.6 Target Therapy Drugs
1.3 United States Prostate Cancer Medicine Market by Application/End Users
  1.3.1 United States Prostate Cancer Medicine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Pharmacy
  1.3.4 Others
1.4 United States Prostate Cancer Medicine Market by Region
  1.4.1 United States Prostate Cancer Medicine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Prostate Cancer Medicine Status and Prospect (2012-2022)
  1.4.3 Southwest Prostate Cancer Medicine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Prostate Cancer Medicine Status and Prospect (2012-2022)
  1.4.5 New England Prostate Cancer Medicine Status and Prospect (2012-2022)
  1.4.6 The South Prostate Cancer Medicine Status and Prospect (2012-2022)
  1.4.7 The Midwest Prostate Cancer Medicine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Prostate Cancer Medicine (2012-2022)
  1.5.1 United States Prostate Cancer Medicine Sales and Growth Rate (2012-2022)
  1.5.2 United States Prostate Cancer Medicine Revenue and Growth Rate (2012-2022)

2 UNITED STATES PROSTATE CANCER MEDICINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Prostate Cancer Medicine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Prostate Cancer Medicine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Prostate Cancer Medicine Average Price by Players/Suppliers (2012-2017)
2.4 United States Prostate Cancer Medicine Market Competitive Situation and Trends
  2.4.1 United States Prostate Cancer Medicine Market Concentration Rate
  2.4.2 United States Prostate Cancer Medicine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Prostate Cancer Medicine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PROSTATE CANCER MEDICINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Prostate Cancer Medicine Sales and Market Share by Region (2012-2017)
3.2 United States Prostate Cancer Medicine Revenue and Market Share by Region (2012-2017)
3.3 United States Prostate Cancer Medicine Price by Region (2012-2017)

4 UNITED STATES PROSTATE CANCER MEDICINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Prostate Cancer Medicine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Prostate Cancer Medicine Revenue and Market Share by Type (2012-2017)
4.3 United States Prostate Cancer Medicine Price by Type (2012-2017)
4.4 United States Prostate Cancer Medicine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PROSTATE CANCER MEDICINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Prostate Cancer Medicine Sales and Market Share by Application (2012-2017)
5.2 United States Prostate Cancer Medicine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PROSTATE CANCER MEDICINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AstraZeneca plc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Prostate Cancer Medicine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca plc Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Active Biotech
  6.2.2 Prostate Cancer Medicine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Active Biotech Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bristol Myers-Squibb
  6.3.2 Prostate Cancer Medicine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Teva Pharmaceuticals Industries Ltd.
  6.4.2 Prostate Cancer Medicine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Johnson & Johnson
  6.5.2 Prostate Cancer Medicine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Johnson & Johnson Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Pfizer Inc.
  6.6.2 Prostate Cancer Medicine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pfizer Inc. Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bayer AG
  6.7.2 Prostate Cancer Medicine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bayer AG Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Abbott Laboratories
  6.8.2 Prostate Cancer Medicine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Abbott Laboratories Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Astellas Pharma Inc.
  6.9.2 Prostate Cancer Medicine Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Roche Holding AG
  6.10.2 Prostate Cancer Medicine Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Roche Holding AG Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 PROSTATE CANCER MEDICINE MANUFACTURING COST ANALYSIS

7.1 Prostate Cancer Medicine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Prostate Cancer Medicine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Prostate Cancer Medicine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Prostate Cancer Medicine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PROSTATE CANCER MEDICINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Prostate Cancer Medicine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Prostate Cancer Medicine Sales Volume Forecast by Type (2017-2022)
11.3 United States Prostate Cancer Medicine Sales Volume Forecast by Application (2017-2022)
11.4 United States Prostate Cancer Medicine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Prostate Cancer Medicine
Figure United States Prostate Cancer Medicine Market Size (K Units) by Type (2012-2022)
Figure United States Prostate Cancer Medicine Sales Volume Market Share by Type (Product Category) in 2016
Figure Hormonal Therapy Drugs Product Picture
Figure Chemotherapy Drugs Product Picture
Figure Immunotherapy Drugs Product Picture
Figure Target Therapy Drugs Product Picture
Figure United States Prostate Cancer Medicine Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Prostate Cancer Medicine by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Prostate Cancer Medicine Market Size (Million USD) by Region (2012-2022)
Figure The West Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Prostate Cancer Medicine Sales (K Units) and Growth Rate (2012-2022)
Figure United States Prostate Cancer Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Prostate Cancer Medicine Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Prostate Cancer Medicine Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Prostate Cancer Medicine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Prostate Cancer Medicine Sales Share by Players/Suppliers
Figure 2017 United States Prostate Cancer Medicine Sales Share by Players/Suppliers
Figure United States Prostate Cancer Medicine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Prostate Cancer Medicine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Prostate Cancer Medicine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Prostate Cancer Medicine Revenue Share by Players/Suppliers
Figure 2017 United States Prostate Cancer Medicine Revenue Share by Players/Suppliers
Table United States Market Prostate Cancer Medicine Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Prostate Cancer Medicine Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Prostate Cancer Medicine Market Share of Top 3 Players/Suppliers
Figure United States Prostate Cancer Medicine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Prostate Cancer Medicine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Prostate Cancer Medicine Product Category
Table United States Prostate Cancer Medicine Sales (K Units) by Region (2012-2017)
Table United States Prostate Cancer Medicine Sales Share by Region (2012-2017)
Figure United States Prostate Cancer Medicine Sales Share by Region (2012-2017)
Figure United States Prostate Cancer Medicine Sales Market Share by Region in 2016
Table United States Prostate Cancer Medicine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Prostate Cancer Medicine Revenue Share by Region (2012-2017)
Figure United States Prostate Cancer Medicine Revenue Market Share by Region (2012-2017)
Figure United States Prostate Cancer Medicine Revenue Market Share by Region in 2016
Table United States Prostate Cancer Medicine Price (USD/Unit) by Region (2012-2017)
Table United States Prostate Cancer Medicine Sales (K Units) by Type (2012-2017)
Table United States Prostate Cancer Medicine Sales Share by Type (2012-2017)
Figure United States Prostate Cancer Medicine Sales Share by Type (2012-2017)
Figure United States Prostate Cancer Medicine Sales Market Share by Type in 2016
Table United States Prostate Cancer Medicine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Prostate Cancer Medicine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prostate Cancer Medicine by Type (2012-2017)
Figure Revenue Market Share of Prostate Cancer Medicine by Type in 2016
Table United States Prostate Cancer Medicine Price (USD/Unit) by Types (2012-2017)
Figure United States Prostate Cancer Medicine Sales Growth Rate by Type (2012-2017)
Table United States Prostate Cancer Medicine Sales (K Units) by Application (2012-2017)
Table United States Prostate Cancer Medicine Sales Market Share by Application (2012-2017)
Figure United States Prostate Cancer Medicine Sales Market Share by Application (2012-2017)
Figure United States Prostate Cancer Medicine Sales Market Share by Application in 2016
Table United States Prostate Cancer Medicine Sales Growth Rate by Application (2012-2017)
Figure United States Prostate Cancer Medicine Sales Growth Rate by Application (2012-2017)
Table AstraZeneca plc Basic Information List
Table AstraZeneca plc Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca plc Prostate Cancer Medicine Sales Growth Rate (2012-2017)
Figure AstraZeneca plc Prostate Cancer Medicine Sales Market Share in United States (2012-2017)
Figure AstraZeneca plc Prostate Cancer Medicine Revenue Market Share in United States (2012-2017)
Table Active Biotech Basic Information List
Table Active Biotech Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Active Biotech Prostate Cancer Medicine Sales Growth Rate (2012-2017)
Figure Active Biotech Prostate Cancer Medicine Sales Market Share in United States (2012-2017)
Figure Active Biotech Prostate Cancer Medicine Revenue Market Share in United States (2012-2017)
Table Bristol Myers-Squibb Basic Information List
Table Bristol Myers-Squibb Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol Myers-Squibb Prostate Cancer Medicine Sales Growth Rate (2012-2017)
Figure Bristol Myers-Squibb Prostate Cancer Medicine Sales Market Share in United States (2012-2017)
Figure Bristol Myers-Squibb Prostate Cancer Medicine Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceuticals Industries Ltd. Basic Information List
Table Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Sales Growth Rate (2012-2017)
Figure Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Prostate Cancer Medicine Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Prostate Cancer Medicine Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Prostate Cancer Medicine Revenue Market Share in United States (2012-2017)
Table Pfizer Inc. Basic Information List
Table Pfizer Inc. Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Inc. Prostate Cancer Medicine Sales Growth Rate (2012-2017)
Figure Pfizer Inc. Prostate Cancer Medicine Sales Market Share in United States (2012-2017)
Figure Pfizer Inc. Prostate Cancer Medicine Revenue Market Share in United States (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer AG Prostate Cancer Medicine Sales Growth Rate (2012-2017)
Figure Bayer AG Prostate Cancer Medicine Sales Market Share in United States (2012-2017)
Figure Bayer AG Prostate Cancer Medicine Revenue Market Share in United States (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Prostate Cancer Medicine Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Prostate Cancer Medicine Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories Prostate Cancer Medicine Revenue Market Share in United States (2012-2017)
Table Astellas Pharma Inc. Basic Information List
Table Astellas Pharma Inc. Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharma Inc. Prostate Cancer Medicine Sales Growth Rate (2012-2017)
Figure Astellas Pharma Inc. Prostate Cancer Medicine Sales Market Share in United States (2012-2017)
Figure Astellas Pharma Inc. Prostate Cancer Medicine Revenue Market Share in United States (2012-2017)
Table Roche Holding AG Basic Information List
Table Roche Holding AG Prostate Cancer Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Holding AG Prostate Cancer Medicine Sales Growth Rate (2012-2017)
Figure Roche Holding AG Prostate Cancer Medicine Sales Market Share in United States (2012-2017)
Figure Roche Holding AG Prostate Cancer Medicine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Medicine
Figure Manufacturing Process Analysis of Prostate Cancer Medicine
Figure Prostate Cancer Medicine Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Medicine Major Players/Suppliers in 2016
Table Major Buyers of Prostate Cancer Medicine
Table Distributors/Traders List
Figure United States Prostate Cancer Medicine Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Prostate Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Prostate Cancer Medicine Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Prostate Cancer Medicine Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Prostate Cancer Medicine Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Prostate Cancer Medicine Sales Volume (K Units) Forecast by Type in 2022
Table United States Prostate Cancer Medicine Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Prostate Cancer Medicine Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Prostate Cancer Medicine Sales Volume (K Units) Forecast by Application in 2022
Table United States Prostate Cancer Medicine Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Prostate Cancer Medicine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Prostate Cancer Medicine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Prostate Cancer Medicine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources